BioSpace News Archive

HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the second quarter and six month periods ending June 30, 2020 on Friday, August 7, 2020 before market open.

OncoSec Medical Incorporated (the “Company” or “OncoSec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the Company will be featured in a live webinar, “Grand Rounds: A Webinar in Biotech and Specialty Pharma,” hosted by James Molloy , Managing Director of Equi

Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by mucus and inflammation, announced publication of results from research conducted at The University of Alabama Birmingham. The research was funded in part by the Cystic Fibrosis Foundation and was conducted at The Rowe Lab at The Gregory Fleming James Cystic Fibrosis Research Center. Res

For the first time, practitioners will be able to leverage dual-energy x-ray technology in a portable system.

Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance Funding to Support Development of New Antibiotics as Part of Broader Industry Effort New Partnership with More than 20 Other Companies Will Focus on Medicines that Address Most Resistant Bacteria and Life-Threatening Infections Builds on Pfizer’s longstanding work to address the global burden of infectious diseases NEW YORK

Merakris Therapeutics, LLC Announces the Commercial Launch of Dermacyte® Matrix and CMS Assignment of an HCPCS Code for Use as a Skin Graft Substitute New HCPCS Code Enables Facility Reimbursement to Physician Offices Performing Skin Graft Substitute Procedures, Benefiting Wound Patients RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )-- Merakris Therapeutics, LLC., a leader in innovative approaches for cutaneous wound healing, announces that the Center

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2020 after the market closes on Thursday, July 23, 2020 , and will host a conference call at 5:00 p.m. ET th

TearLab Corporation (TearLab), a leader in diagnostics for dry eye disease (DED), today announced their acquisition by Accelmed Partners II (AP-II). As a newly formed private company, TearLab is now positioned to pursue further devel

Publix Pharmacy is now filling prescriptions for pet medications in Florida.

United Spinal Association announced today that it has appointed David M. Capozzi, former Executive Director of the U.S. Access Board and Jenny M. Lieberman, PhD, OTR/L, ATP, Department of Rehabilitation, The Mount Sinai Hospital to its board of directors.